Latest filing published 30 Sept 2026 for Dr. Lal Pathlabs, €19k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Munender Soperna is a declared insider of Dr. Lal Path Labs Ltd., with filings sourced from SEBI (PIT + SAST). Between 21 May 2026 and 30 September 2026, the trades on record add up to 7 filings.
On the market, this insider has only sold: 5 sales, €185k in total. The rest of the record consists of 2 share grants.
The newest entry dates from 30 September 2026: a share grant of €19k, in Dr. Lal Path Labs Ltd. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations